Ofloxacin Tablets

This product is a DNA helicase inhibitor, which has strong antibacterial effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. There is no cross-resistance with other types of antibacterial drugs.

Ofloxacin

This product is off-white tablets, odorless and bitter.

It is mainly used for acute and chronic bacterial infections of urinary, reproductive, digestive, respiratory systems, skin, soft tissues, etc. caused by sensitive bacteria. It includes patients in internal medicine, surgery, urology, obstetrics and gynecology, ophthalmology, otolaryngology, dermatology, etc.

Oral administration: Adults: 0.2-0.3g at a time, twice a day or as directed by a doctor.

Nausea, vomiting, stomach and abdominal discomfort, insomnia, dizziness, headache, rash and increased serum alanine aminotransferase may occur occasionally, but they are generally tolerated and disappear after drug discontinuation.

It should not be used by people who are allergic to quinolones, children, pregnant and lactating women, and patients with epilepsy.

Precautions for children: The safety of this product in infants and adolescents under 18 years of age has not been determined. However, this product can cause joint lesions when used in several young animals. Therefore, it should not be used in children and adolescents under 18 years of age. Precautions for pregnancy and lactation: Animal experiments have not confirmed that quinolones are teratogenic, but studies on the use of drugs in pregnant women have not yet reached a clear conclusion. Since this drug can cause joint lesions in underage animals, it is contraindicated for pregnant women, and lactating women should suspend breastfeeding when using this product. Precautions for the elderly: Elderly patients often have impaired renal function, and since this product is partially excreted through the kidneys, it needs to be used in reduced doses.

It can increase the blood concentrations of drugs such as cyclosporine and probenecid and interfere with the metabolism of caffeine.

Keep in airtight container and away from light.

0.1g

Tentative two years

Harbin Pharmaceutical Group Pharmaceutical Factory No.6

• Founded in:

  1994-05-20

• Address:

  No. 326, Nanzhi Road, Daowai District, Harbin, Xingye East Road, Limin Economic and Technological Development Zone, Harbin

• Tax NO.:

  912301001270449678

• Registered Funds:

  -

• Website:

  Log in to view

• Email:

  Log in to view